Clinical Trial Update: Visugromab in Cachexia International Trial [Phase 2, Phase 3]

View source ↗

Summary

Visugromab is being studied in international Phase 2 and Phase 3 trials for cancer-associated cachexia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-associated Cachexia

Drugs mentioned

• Visugromab (Visugromab)

Snippet

Sponsor: CatalYm GmbH | Conditions: Cancer-associated Cachexia | Phase 2, Phase 3 | Status: RECRUITING